In a world where one in every two people will be diagnosed with cancer in their lifetime, today we launch Working with Cancer at the World Economic Forum in Davos, rallying some of the world’s most influential companies around the commitment to building the most open, supportive, and recovery-forward work cultures for their employees.
Working with Cancer aims to address the unsettling reality that 50% of cancer patients are afraid to tell their employer about their diagnosis, despite 92% feeling that support at work positively impacts their health. Our cross-industry coalition is supported by leading cancer organizations including Memorial Sloan Kettering Cancer Center, Macmillan Cancer Support, Cancer@Work, Working With Cancer and the Gustave Roussy Institute to support our pledge to create more recovery-forward workplaces.
“It is a tough reality, but whether directly or indirectly, every one of us will have to confront cancer in our lives and in our workplaces. Companies have a key role to play in that. Working with Cancer is an increasingly important initiative, on a front that many businesses are already invested in. By making their existing efforts more accessible and visible, together we can reduce the anxiety and stigma of cancer in the workplace and positively impact our people’s health. Through a truly collaborative approach, a light lift from everyone becomes deep and lasting impact for cancer patients at work” - Arthur Sadoun, CEO of Publicis Groupe.
At launch, Working with Cancer already has the support of key global organizations including AbbVie, Adobe, AXA, Bank of America, BNP Paribas, BT Group, Carrefour, Citi, EE, Google, Haleon, HPE, Haymarket Media Group, Labcorp, L'Oréal, Lloyds Banking Group, LVMH, Marriott International, McDonald's’, Meta, Mondelēz International, Microsoft, MSD, Nestlé, Orange, Omnicom, PepsiCo, Reckitt, Renault Group, Sanofi, Sodexo, Toyota Motor Corporation, Unilever, Verizon, and Walmart.
You can show your support and encourage others to take the pledge here.
Watch the film:
Comments